The present study demonstrates that CCL2 in astrocytes and its receptor CCR2 in monocytes/macrophages and microglia are significantly upregulated at the mRNA and protein level in hippocampal lesions of MS patients. The gene discussed is CCR2; the disease is myeloid sarcoma.